AVO — Advanced Oncotherapy Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Advanced Oncotherapy, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.7 | -21.1 | -20.8 | -25.3 | -29.5 |
| Depreciation | |||||
| Non-Cash Items | -0.136 | 6.1 | 2.08 | 6.84 | 9.5 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.85 | 12.9 | -6.86 | -4.12 | -11.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.59 | -1.66 | -23.6 | -20.2 | -29.6 |
| Capital Expenditures | -8.56 | -12.1 | -12 | -7.44 | -9.29 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.013 | 0.326 | 0.003 | 0 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.56 | -12.1 | -11.7 | -7.43 | -9.29 |
| Financing Cash Flow Items | 0.009 | -0.626 | -0.665 | -1.06 | 1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.8 | 14.7 | 37.5 | 26.7 | 40.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.39 | 0.957 | 2.22 | -0.918 | 1.94 |